As part of our efforts to support the growth of the regional Complementary Health Product (CHP) sector, SeerPharma, with support from SPRING Singapore* and The Medicine Manufacturing Association of Singapore (TMMAS), led a delegation of Complementary Health Product SMEs from Singapore to Australia in August.
The study mission achieved the following objectives:
- LEARN FROM GMP BEST PRACTICES
- Updated on complementary medicine GMP developments in the Australian CHP sector and learnt from best practices in GMP.
- IMPROVE MARKET ACCESS
- Explored cross-border business partnerships for Singaporean and Australian CHP companies.
- DRIVE EVIDENCE-BASED INNOVATION
- Explored the latest developments, opportunities, and challenges of evidence-based research and innovation.
SeerPharma is actively working with a number of complementary medicine manufacturers and organisations in region, and is proud to assist in forging ties between companies and organisations throughout the Asia-Pacific region.
Contact us should you wish to learn more about the visit, and if you’re interested in forging closer ties with complementary medicine companies in the region.
*SPRING Singapore is an agency under the Ministry of Trade and Industry responsible for helping Singapore enterprises grow and building trust in Singapore products and services.
This post comes from our July 2016 Journal. You may also be interested in this post:
